Concepts (336)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 26 | 2022 | 315 | 4.370 |
Why?
|
| Thrombosis | 20 | 2023 | 495 | 3.290 |
Why?
|
| Venules | 9 | 2022 | 28 | 1.880 |
Why?
|
| Neutrophils | 9 | 2021 | 372 | 1.470 |
Why?
|
| von Willebrand Factor | 6 | 2024 | 192 | 1.400 |
Why?
|
| Histones | 3 | 2022 | 518 | 1.260 |
Why?
|
| von Willebrand Diseases | 2 | 2022 | 55 | 1.180 |
Why?
|
| Cornea | 10 | 2024 | 566 | 1.100 |
Why?
|
| Fluorescent Dyes | 5 | 2018 | 251 | 1.010 |
Why?
|
| Endotoxemia | 4 | 2012 | 54 | 1.000 |
Why?
|
| Epithelium, Corneal | 8 | 2024 | 174 | 0.940 |
Why?
|
| Microcirculation | 6 | 2021 | 111 | 0.900 |
Why?
|
| Capillary Permeability | 9 | 2005 | 72 | 0.870 |
Why?
|
| Endothelium, Vascular | 7 | 2020 | 471 | 0.840 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2022 | 140 | 0.820 |
Why?
|
| Corneal Injuries | 6 | 2023 | 35 | 0.780 |
Why?
|
| Vasculitis | 2 | 2021 | 47 | 0.780 |
Why?
|
| Platelet Aggregation | 9 | 2016 | 104 | 0.760 |
Why?
|
| CD18 Antigens | 2 | 2021 | 44 | 0.750 |
Why?
|
| P-Selectin | 7 | 2015 | 69 | 0.740 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 8 | 0.710 |
Why?
|
| Hyperemia | 1 | 2021 | 31 | 0.700 |
Why?
|
| Cell Degranulation | 1 | 2021 | 28 | 0.700 |
Why?
|
| Erythrocytes | 2 | 2021 | 191 | 0.700 |
Why?
|
| Nitric Oxide Synthase | 5 | 2007 | 168 | 0.690 |
Why?
|
| Mast Cells | 1 | 2021 | 65 | 0.680 |
Why?
|
| Animals | 55 | 2025 | 34375 | 0.670 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2024 | 124 | 0.630 |
Why?
|
| Mice | 39 | 2025 | 18488 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 22 | 2024 | 4769 | 0.580 |
Why?
|
| Intravital Microscopy | 1 | 2018 | 20 | 0.560 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 613 | 0.530 |
Why?
|
| Microvessels | 2 | 2020 | 65 | 0.520 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2025 | 551 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.510 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2002 | 57 | 0.500 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 314 | 0.490 |
Why?
|
| Platelet Activation | 5 | 2020 | 67 | 0.480 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2015 | 2 | 0.480 |
Why?
|
| Neutrophil Activation | 2 | 2005 | 12 | 0.470 |
Why?
|
| Antithrombin III | 1 | 2015 | 23 | 0.470 |
Why?
|
| Nitric Oxide | 3 | 2007 | 466 | 0.460 |
Why?
|
| Sepsis | 3 | 2010 | 501 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 366 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.440 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 131 | 0.440 |
Why?
|
| Wound Healing | 8 | 2021 | 476 | 0.440 |
Why?
|
| Acetaminophen | 1 | 2015 | 97 | 0.430 |
Why?
|
| Inflammation | 6 | 2022 | 1492 | 0.430 |
Why?
|
| Diet, High-Fat | 5 | 2024 | 264 | 0.420 |
Why?
|
| Hepatocytes | 1 | 2015 | 234 | 0.420 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2023 | 62 | 0.410 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 142 | 0.410 |
Why?
|
| Serum Albumin | 1 | 2013 | 110 | 0.390 |
Why?
|
| Fibrin | 4 | 2024 | 64 | 0.360 |
Why?
|
| Obesity | 6 | 2024 | 2390 | 0.350 |
Why?
|
| Collagen | 4 | 2023 | 289 | 0.330 |
Why?
|
| Muscle, Skeletal | 3 | 2005 | 1002 | 0.310 |
Why?
|
| Hemostasis | 3 | 2019 | 73 | 0.300 |
Why?
|
| Enzyme Inhibitors | 3 | 2002 | 566 | 0.290 |
Why?
|
| Cell Movement | 6 | 2021 | 881 | 0.290 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 421 | 0.290 |
Why?
|
| Serum Albumin, Bovine | 4 | 2003 | 53 | 0.280 |
Why?
|
| Electromagnetic Fields | 1 | 2007 | 24 | 0.270 |
Why?
|
| Mice, Knockout | 13 | 2019 | 3864 | 0.270 |
Why?
|
| Capillaries | 2 | 2005 | 67 | 0.260 |
Why?
|
| Endothelial Cells | 1 | 2010 | 536 | 0.260 |
Why?
|
| Cell Communication | 2 | 2005 | 196 | 0.260 |
Why?
|
| Dyslipidemias | 2 | 2020 | 247 | 0.260 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2007 | 77 | 0.250 |
Why?
|
| Edema | 1 | 2007 | 139 | 0.250 |
Why?
|
| Rats | 8 | 2007 | 3460 | 0.240 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 232 | 0.240 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 426 | 0.240 |
Why?
|
| Mitochondria, Muscle | 1 | 2005 | 37 | 0.230 |
Why?
|
| Male | 28 | 2024 | 65266 | 0.230 |
Why?
|
| Endotoxins | 1 | 2005 | 50 | 0.230 |
Why?
|
| Mesentery | 2 | 2002 | 28 | 0.230 |
Why?
|
| Albumins | 2 | 2002 | 92 | 0.230 |
Why?
|
| Arterioles | 1 | 2005 | 38 | 0.230 |
Why?
|
| Muscle Contraction | 1 | 2005 | 154 | 0.230 |
Why?
|
| Oculomotor Muscles | 1 | 2005 | 81 | 0.220 |
Why?
|
| Phagocytosis | 3 | 2024 | 191 | 0.220 |
Why?
|
| Megakaryocytes | 1 | 2025 | 41 | 0.220 |
Why?
|
| omega-N-Methylarginine | 2 | 2002 | 10 | 0.220 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 227 | 0.220 |
Why?
|
| Calcium | 2 | 2007 | 1041 | 0.210 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 4696 | 0.210 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 171 | 0.210 |
Why?
|
| Cardiolipins | 1 | 2024 | 19 | 0.210 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 168 | 0.210 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2024 | 25 | 0.210 |
Why?
|
| Leukocytes | 4 | 2020 | 211 | 0.210 |
Why?
|
| Pandemics | 2 | 2022 | 1164 | 0.200 |
Why?
|
| Secretory Vesicles | 3 | 2019 | 21 | 0.200 |
Why?
|
| Corneal Stroma | 1 | 2024 | 75 | 0.200 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 156 | 0.200 |
Why?
|
| Models, Animal | 2 | 2021 | 460 | 0.200 |
Why?
|
| Lipopolysaccharides | 3 | 2012 | 302 | 0.200 |
Why?
|
| Light | 2 | 2004 | 174 | 0.200 |
Why?
|
| Sucrose | 1 | 2023 | 36 | 0.190 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2022 | 43 | 0.190 |
Why?
|
| Hemostatics | 1 | 2022 | 57 | 0.190 |
Why?
|
| Humans | 26 | 2024 | 131679 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2005 | 1151 | 0.180 |
Why?
|
| Exocytosis | 2 | 2019 | 66 | 0.180 |
Why?
|
| Fluorescein-5-isothiocyanate | 4 | 2003 | 28 | 0.180 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 109 | 0.170 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2021 | 60 | 0.170 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 314 | 0.170 |
Why?
|
| Macrophages | 2 | 2024 | 666 | 0.170 |
Why?
|
| Meibomian Glands | 1 | 2020 | 43 | 0.170 |
Why?
|
| Hypertrophy | 1 | 2020 | 101 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2011 | 121 | 0.160 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2020 | 66 | 0.160 |
Why?
|
| Face | 1 | 2021 | 196 | 0.150 |
Why?
|
| Splanchnic Circulation | 4 | 2002 | 49 | 0.150 |
Why?
|
| Catalytic Domain | 3 | 2023 | 161 | 0.150 |
Why?
|
| Tears | 1 | 2020 | 185 | 0.150 |
Why?
|
| Munc18 Proteins | 1 | 2019 | 20 | 0.150 |
Why?
|
| Ischemia | 1 | 2002 | 355 | 0.150 |
Why?
|
| Regeneration | 1 | 2021 | 231 | 0.150 |
Why?
|
| Phosphatidylserines | 3 | 2013 | 46 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2020 | 234 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 363 | 0.140 |
Why?
|
| Fibrinogen | 4 | 2023 | 157 | 0.140 |
Why?
|
| Cytokines | 2 | 2015 | 1348 | 0.140 |
Why?
|
| Staining and Labeling | 1 | 2018 | 172 | 0.130 |
Why?
|
| Proteins | 1 | 2003 | 1027 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1947 | 0.130 |
Why?
|
| Actins | 2 | 2016 | 317 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 2 | 2023 | 53 | 0.130 |
Why?
|
| Antibodies | 1 | 2018 | 357 | 0.130 |
Why?
|
| Thrombin | 3 | 2013 | 58 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2021 | 724 | 0.120 |
Why?
|
| Platelet Function Tests | 2 | 2013 | 38 | 0.120 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 10 | 0.120 |
Why?
|
| Corneal Keratocytes | 1 | 2015 | 5 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2011 | 31 | 0.110 |
Why?
|
| Hypersensitivity | 1 | 2018 | 231 | 0.110 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 82 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 42 | 0.110 |
Why?
|
| Gene Expression | 2 | 2012 | 1502 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 127 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 69 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 272 | 0.110 |
Why?
|
| Calcineurin | 1 | 2014 | 59 | 0.110 |
Why?
|
| Platelet Storage Pool Deficiency | 1 | 1994 | 2 | 0.110 |
Why?
|
| Anesthesia, General | 1 | 2015 | 128 | 0.100 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 48 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2015 | 376 | 0.100 |
Why?
|
| Blood Coagulation | 2 | 2016 | 123 | 0.100 |
Why?
|
| Diet | 1 | 2019 | 1121 | 0.090 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1994 | 152 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 27 | 0.090 |
Why?
|
| Xanthenes | 2 | 2002 | 6 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2014 | 4683 | 0.090 |
Why?
|
| Research Design | 2 | 2007 | 723 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 1994 | 303 | 0.080 |
Why?
|
| Blood Cell Count | 1 | 2010 | 64 | 0.080 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 57 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 233 | 0.080 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 76 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2012 | 2971 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1613 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2011 | 128 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 222 | 0.080 |
Why?
|
| Neurons | 1 | 2019 | 1990 | 0.080 |
Why?
|
| Rana pipiens | 2 | 2002 | 29 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 1788 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 824 | 0.080 |
Why?
|
| Time Factors | 3 | 2021 | 6279 | 0.080 |
Why?
|
| Complement C3 | 1 | 2009 | 43 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 341 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2023 | 421 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2008 | 116 | 0.070 |
Why?
|
| Arginine | 3 | 2005 | 344 | 0.070 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2008 | 7 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2021 | 495 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2008 | 50 | 0.070 |
Why?
|
| Carrageenan | 1 | 2007 | 4 | 0.070 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 36 | 0.070 |
Why?
|
| Perfusion | 2 | 2002 | 210 | 0.070 |
Why?
|
| Swine | 2 | 2002 | 1190 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 62 | 0.070 |
Why?
|
| Shear Strength | 1 | 2007 | 15 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 50 | 0.070 |
Why?
|
| Histamine | 1 | 2007 | 52 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1610 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2011 | 900 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1024 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 199 | 0.060 |
Why?
|
| Chlorophenols | 1 | 2005 | 2 | 0.060 |
Why?
|
| Calcimycin | 1 | 2005 | 19 | 0.060 |
Why?
|
| Citrate (si)-Synthase | 1 | 2005 | 17 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2005 | 41 | 0.060 |
Why?
|
| Heparin | 1 | 2007 | 206 | 0.060 |
Why?
|
| Keratitis | 1 | 2006 | 105 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2005 | 37 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2008 | 464 | 0.060 |
Why?
|
| Caffeine | 1 | 2005 | 67 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 91 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2005 | 114 | 0.060 |
Why?
|
| Female | 7 | 2021 | 71185 | 0.060 |
Why?
|
| von Willebrand Disease, Type 3 | 1 | 2024 | 6 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2007 | 685 | 0.050 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2024 | 11 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2024 | 20 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2004 | 72 | 0.050 |
Why?
|
| Isoelectric Point | 1 | 2003 | 16 | 0.050 |
Why?
|
| Lactalbumin | 1 | 2003 | 11 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2025 | 349 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 22 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 179 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1236 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2003 | 297 | 0.050 |
Why?
|
| Adult | 4 | 2015 | 31719 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2022 | 83 | 0.050 |
Why?
|
| Lymph | 1 | 2002 | 7 | 0.050 |
Why?
|
| Mineral Oil | 1 | 2002 | 5 | 0.050 |
Why?
|
| Emollients | 1 | 2002 | 2 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 62 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2007 | 595 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 99 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2021 | 42 | 0.050 |
Why?
|
| Biological Transport | 1 | 2002 | 333 | 0.040 |
Why?
|
| Intra-Abdominal Fat | 1 | 2021 | 64 | 0.040 |
Why?
|
| Species Specificity | 1 | 2002 | 519 | 0.040 |
Why?
|
| Binding Sites | 1 | 2024 | 1202 | 0.040 |
Why?
|
| Research | 1 | 2003 | 268 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2014 | 810 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 2020 | 11 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2020 | 16 | 0.040 |
Why?
|
| Anura | 1 | 2000 | 9 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 73 | 0.040 |
Why?
|
| Bradykinin | 1 | 2000 | 45 | 0.040 |
Why?
|
| Ceramides | 1 | 2020 | 46 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 127 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 260 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2015 | 6494 | 0.040 |
Why?
|
| Epididymis | 1 | 2020 | 66 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 153 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2014 | 1571 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2000 | 195 | 0.040 |
Why?
|
| Neoplasms | 1 | 2015 | 2969 | 0.040 |
Why?
|
| Photochemistry | 1 | 1999 | 21 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2019 | 34 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2568 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2014 | 769 | 0.040 |
Why?
|
| Histidine | 1 | 1999 | 74 | 0.040 |
Why?
|
| Arteries | 1 | 2000 | 210 | 0.040 |
Why?
|
| Hemolysis | 1 | 1999 | 86 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 3101 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 1086 | 0.040 |
Why?
|
| Critical Illness | 1 | 2022 | 615 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 366 | 0.030 |
Why?
|
| Triglycerides | 1 | 2020 | 605 | 0.030 |
Why?
|
| Body Composition | 1 | 2020 | 550 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 366 | 0.030 |
Why?
|
| Talin | 1 | 2016 | 11 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 283 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 1265 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 713 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2005 | 2437 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 420 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 1626 | 0.030 |
Why?
|
| Heart | 1 | 2000 | 675 | 0.030 |
Why?
|
| Endosonography | 1 | 2015 | 79 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 107 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2014 | 39 | 0.030 |
Why?
|
| Chlorides | 1 | 2014 | 99 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cofilin 1 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 126 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 312 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 91 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2012 | 17 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 28 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 260 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1996 | 400 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 773 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1996 | 381 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 226 | 0.020 |
Why?
|
| Endocytosis | 1 | 2012 | 129 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 419 | 0.020 |
Why?
|
| Vasodilation | 2 | 2005 | 174 | 0.020 |
Why?
|
| Middle Aged | 2 | 2015 | 28888 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 328 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2009 | 12 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 38 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2143 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 59 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 588 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 60 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2009 | 7 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 216 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2363 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 792 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 2008 | 5 | 0.020 |
Why?
|
| Maleimides | 1 | 2008 | 10 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2008 | 35 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2008 | 64 | 0.020 |
Why?
|
| Milk Proteins | 1 | 2008 | 86 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3405 | 0.020 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 25 | 0.020 |
Why?
|
| Spleen | 1 | 2008 | 256 | 0.020 |
Why?
|
| CD11a Antigen | 1 | 2007 | 11 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 29 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 482 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 97 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 343 | 0.020 |
Why?
|
| Pterins | 1 | 2005 | 6 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 312 | 0.010 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2005 | 14 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 48 | 0.010 |
Why?
|
| Homocysteine | 1 | 2005 | 118 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2012 | 947 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 187 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2006 | 222 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4516 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 179 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 240 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 589 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6924 | 0.010 |
Why?
|
| Antioxidants | 1 | 2005 | 336 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1861 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 536 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 21260 | 0.010 |
Why?
|
| Ascites | 1 | 1996 | 99 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1996 | 114 | 0.010 |
Why?
|
| Hypoxia | 1 | 1996 | 245 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1996 | 275 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 1168 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1996 | 463 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1996 | 901 | 0.000 |
Why?
|